NUSINERSEN

Brand name:

• Spinraza®

Form and strength:

Please search for and view the medicine's Public Summary Document (PSD) for more information

Condition/indication:
(therapeutic use)

• Spinal muscular atrophy

Listing requested:

Please see PSD for more information

Funding program:

Please see PSD for more information

Request authority level:

Please see PSD for more information

PBAC submission type:

New listing (Minor)

Comment:

Submission received deferred outcome at the July 2019 PBAC meeting.

Submission sponsor:

Biogen Australia Pty Ltd

Other PBAC consideration:

• NUSINERSEN

Submission received for:

Not applicable

Opportunity for consumer comment:

Not applicable

PBAC meeting:

Held on 06/11/2019

PBAC outcome published:

Not Recommended (see PBAC Outcomes)

Lodgement of required documentation:

Not applicable

Agreement to listing arrangements:

Not applicable

Government processes:

Not applicable

Medicine listed on the PBS:

Not applicable

---